Uncovering the Mechanisms of Adenosine Receptor-Mediated Pain Control: Focus on the A

Adenosine A3 Receptor Agonists / therapeutic use Animals Astrocytes / metabolism Calcium Signaling / drug effects Ganglia, Spinal / metabolism Humans Microglia / metabolism Pain / drug therapy Receptor, Adenosine A3 / metabolism
A3 adenosine receptor Ca2+ currents T cells adenosine dorsal root ganglion neurons interleukin-10 neuropathic pain visceral pain

Journal

International journal of molecular sciences
ISSN: 1422-0067
Titre abrégé: Int J Mol Sci
Pays: Switzerland
ID NLM: 101092791

Informations de publication

Date de publication:
26 Jul 2021
Historique:
received: 05 07 2021
revised: 19 07 2021
accepted: 20 07 2021
entrez: 7 8 2021
pubmed: 8 8 2021
medline: 10 9 2021
Statut: epublish

Résumé

Agonists of the G

Identifiants

DOI: 10.3390/ijms22157952 PMID: 34360719 PMC: PMC8347395
pubmed: 34360719
pii: ijms22157952
doi: 10.3390/ijms22157952
pmc: PMC8347395
pii:
doi:

Substances chimiques

ADORA3 protein, human 0
Adenosine A3 Receptor Agonists 0
Receptor, Adenosine A3 0

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : Fondazione Italiana Sclerosi Multipla
ID : 2019/R-Single/036
Organisme : NIH HHS
ID : NIH/NCI R01 CA169519
Pays : United States
Organisme : NIDDK NIH HHS
ID : ZIADK31117
Pays : United States
Organisme : University of Florence
ID : Fondi Ateneo

Références

J Med Chem. 2019 Sep 26;62(18):8511-8531
pubmed: 31453698
Neuromodulation. 2016 Jul;19(5):522-32
pubmed: 26856969
Front Pharmacol. 2021 Jan 29;11:625662
pubmed: 33584309
Pain. 2020 Jul;161(7):1425-1441
pubmed: 32187120
Anesth Analg. 2005 Nov;101(5):1417-21
pubmed: 16244004
Pain. 2018 Jun;159(6):1025-1034
pubmed: 29419652
Brain Behav Immun. 2015 Feb;44:91-9
pubmed: 25220279
Eur J Pharmacol. 1995 Aug 15;281(3):311-8
pubmed: 8521915
Neuroscience. 1990;38(3):757-62
pubmed: 1980146
Brain Behav Immun. 2018 Mar;69:470-479
pubmed: 29366930
Eur J Pharmacol. 1988 Oct 26;156(1):25-34
pubmed: 3145208
Curr Pharm Des. 2019;25(25):2697-2715
pubmed: 31333094
Biochem Pharmacol. 2018 May;151:307-313
pubmed: 29427624
Int J Mol Sci. 2020 Nov 18;21(22):
pubmed: 33218074
J Immunol. 2013 Jan 1;190(1):138-46
pubmed: 23225885
Brain. 2015 Jan;138(Pt 1):28-35
pubmed: 25414036
Neuroscience. 1995 Jul;67(1):189-95
pubmed: 7477899
Front Cell Neurosci. 2019 Mar 28;13:124
pubmed: 30983976
Biomed Pharmacother. 2021 Mar;135:111164
pubmed: 33385856
Eur J Pharmacol. 1997 Aug 20;333(1):1-7
pubmed: 9311654
Pain. 1996 Dec;68(2-3):217-27
pubmed: 9121808
Purinergic Signal. 2021 Jun;17(2):303-312
pubmed: 33860899
Eur J Pharmacol. 1993 Jan 26;231(1):139-42
pubmed: 8444279
J Physiol. 1986 Jan;370:75-90
pubmed: 2420981
Purinergic Signal. 2015 Sep;11(3):371-87
pubmed: 26111639
Arthritis Rheum. 1995 Aug;38(8):1040-5
pubmed: 7662029
Neural Regen Res. 2021 Sep;16(9):1686-1692
pubmed: 33510056
Pharmacol Toxicol. 1992 Jun;70(6 Pt 1):434-8
pubmed: 1438021
J Clin Med. 2020 May 06;9(5):
pubmed: 32384746
Nat Rev Rheumatol. 2017 Jan;13(1):41-51
pubmed: 27829671
Pain. 2019 May;160(5):1103-1118
pubmed: 31008816
Curr Neuropharmacol. 2017;15(2):217-231
pubmed: 26861472
Front Pharmacol. 2018 Apr 24;9:399
pubmed: 29740323
Curr Med Chem. 2018;25(32):3830-3865
pubmed: 28699505
J Investig Med. 1995 Feb;43(1):50-7
pubmed: 7719759
Purinergic Signal. 2014 Sep;10(3):465-75
pubmed: 24595664
Int J Mol Sci. 2020 Dec 18;21(24):
pubmed: 33353217
J Med Chem. 2016 Apr 14;59(7):3249-63
pubmed: 26890707
Neuroscience. 1991;44(1):131-5
pubmed: 1722888
Physiol Rev. 2012 Jan;92(1):193-235
pubmed: 22298656
Prog Neurobiol. 2011 Oct;95(2):229-74
pubmed: 21907261
J Appl Physiol (1985). 1994 Jan;76(1):5-13
pubmed: 8175547
J Med Chem. 2014 Dec 11;57(23):9901-14
pubmed: 25422861
J Neurosci. 2015 Apr 15;35(15):6057-67
pubmed: 25878279
J Bone Miner Res. 2013 Jan;28(1):92-107
pubmed: 22903605
Brain Res Bull. 2019 Sep;151:174-180
pubmed: 31132418
Pain. 2020 Sep 1;161(9):2179-2190
pubmed: 32379223
Neuropharmacology. 2013 Apr;67:511-20
pubmed: 23261865
J Neurophysiol. 2012 Feb;107(3):1009-21
pubmed: 22131374
Expert Opin Investig Drugs. 2000 Oct;9(10):2403-10
pubmed: 11060815
Cell Rep. 2016 Jun 28;16(1):106-119
pubmed: 27320922
Nat Rev Drug Discov. 2006 Mar;5(3):247-64
pubmed: 16518376
J Physiol. 1989 Apr;411:585-95
pubmed: 2614735
Pain. 2014 Dec;155(12):2560-2567
pubmed: 25242567
J Pharmacol Exp Ther. 2020 Aug;374(2):331-341
pubmed: 32434943
Mar Drugs. 2013 Mar 07;11(3):680-99
pubmed: 23470283
Front Pharmacol. 2017 Sep 25;8:661
pubmed: 28993732
J Med Chem. 2013 Jul 25;56(14):5949-63
pubmed: 23789857
Brain Behav Immun. 2013 Oct;33:112-22
pubmed: 23811314
Pharmacol Rev. 2019 Jul;71(3):345-382
pubmed: 31235653
Korean J Anesthesiol. 2019 Feb;72(1):60-67
pubmed: 29969887
Exp Neurol. 2013 Dec;250:189-93
pubmed: 24056265
Neurosci Lett. 2002 Aug 9;328(2):129-32
pubmed: 12133572
Pharmacol Rev. 2011 Mar;63(1):1-34
pubmed: 21303899
Purinergic Signal. 2020 Sep;16(3):367-377
pubmed: 32720036
J Clin Invest. 2021 Apr 1;131(7):
pubmed: 33621215
Neuroscience. 2016 Dec 3;338:1-18
pubmed: 26500181
J Biol Chem. 1993 Aug 15;268(23):16887-90
pubmed: 8349579
Lancet Neurol. 2015 Feb;14(2):162-73
pubmed: 25575710
Neuropharmacology. 2016 May;104:105-30
pubmed: 26581499
J Rheumatol. 2008 Jan;35(1):41-8
pubmed: 18050382
ACS Med Chem Lett. 2015 May 20;6(7):804-8
pubmed: 26191370
Pain. 2020 Jan;161(1):177-184
pubmed: 31490328
Eur J Pharmacol. 2000 Jul 7;399(2-3):131-9
pubmed: 10884512
FASEB J. 2012 May;26(5):1855-65
pubmed: 22345405
Brain Behav Immun. 2018 Mar;69:60-61
pubmed: 29499304
Eur J Pharmacol. 1998 Apr 17;347(1):1-11
pubmed: 9650842
J Neurosci Res. 2021 Jun 1;:
pubmed: 34075613
Trends Mol Med. 2011 Apr;17(4):188-96
pubmed: 21236731

Auteurs

Elisabetta Coppi (E)

Department NEUROFARBA, Division of Pharmacology and Toxicology, University of Florence, 50139 Firenze, Italy.
ORCID: 0000-0003-4434-5919

Federica Cherchi (F)

Department NEUROFARBA, Division of Pharmacology and Toxicology, University of Florence, 50139 Firenze, Italy.
ORCID: 0000-0001-6742-456X

Elena Lucarini (E)

Department NEUROFARBA, Division of Pharmacology and Toxicology, University of Florence, 50139 Firenze, Italy.
ORCID: 0000-0002-3459-2660

Carla Ghelardini (C)

Department NEUROFARBA, Division of Pharmacology and Toxicology, University of Florence, 50139 Firenze, Italy.

Felicita Pedata (F)

Department NEUROFARBA, Division of Pharmacology and Toxicology, University of Florence, 50139 Firenze, Italy.

Kenneth A Jacobson (KA)

Molecular Recognition Section, Laboratory of Bioorganic Chemistry, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, MD 20892-0810, USA.
ORCID: 0000-0001-8104-1493

Lorenzo Di Cesare Mannelli (L)

Department NEUROFARBA, Division of Pharmacology and Toxicology, University of Florence, 50139 Firenze, Italy.
ORCID: 0000-0001-8374-4432

Anna Maria Pugliese (AM)

Department NEUROFARBA, Division of Pharmacology and Toxicology, University of Florence, 50139 Firenze, Italy.

Daniela Salvemini (D)

Department of Pharmacology and Physiology, Saint Louis University School of Medicine, St. Louis, MO 63104, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female

Evaluation of Low-Value Services Across Major Medicare Advantage Insurers and Traditional Medicare.

Ciara Duggan, Adam L Beckman, Ishani Ganguli et al.
1.00
Humans United States Aged Cross-Sectional Studies Medicare Part C

Effectiveness of Virtual Yoga for Chronic Low Back Pain: A Randomized Clinical Trial.

Hallie Tankha, Devyn Gaskins, Amanda Shallcross et al.
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH

questionsmedicales.fr › Actions chimiques et utilisations › Actions pharmacologiques › Effets physiologiques des médicaments › Agents neuromédiateurs › Agents purinergiques › Agonistes purinergiques › Agonistes des récepteurs purinergiques P1 › Agonistes du récepteur A3 à l'adénosine › Uncovering the Mechanisms of Adenosine...
questionsmedicales.fr › Eucaryotes › Animaux › Uncovering the Mechanisms of Adenosine...
questionsmedicales.fr › Cellules › Névroglie › Astrocytes › Uncovering the Mechanisms of Adenosine...
questionsmedicales.fr › Phénomènes physiologiques cellulaires › Transduction du signal › Systèmes de seconds messagers › Signalisation calcique › Uncovering the Mechanisms of Adenosine...
questionsmedicales.fr › Système nerveux › Système nerveux périphérique › Nerfs périphériques › Nerfs spinaux › Racines des nerfs spinaux › Ganglions sensitifs des nerfs spinaux › Uncovering the Mechanisms of Adenosine...
questionsmedicales.fr › Eucaryotes › Animaux › Chordés › Vertébrés › Mammifères › Eutheria › Primates › Haplorhini › Catarrhini › Hominidae › Humains › Uncovering the Mechanisms of Adenosine...
questionsmedicales.fr › Cellules › Névroglie › Microglie › Uncovering the Mechanisms of Adenosine...
questionsmedicales.fr › Phénomènes physiologiques de l'appareil locomoteur et du système nerveux › Phénomènes physiologiques du système nerveux › Sensation › Douleur › Uncovering the Mechanisms of Adenosine...
questionsmedicales.fr › Acides aminés, peptides et protéines › Protéines › Protéines membranaires › Récepteurs de surface cellulaire › Récepteurs aux neuromédiateurs › Récepteurs purinergiques › Récepteurs purinergiques P1 › Récepteur A3 à l'adénosine › Uncovering the Mechanisms of Adenosine...